05046501 is referenced by 165 patents and cites 5 patents.

A method of identifying atherosclerotic plaque versus structurally viable tissue includes the steps of emitting a fluorescent beam at a single excitation wavelength of between 350 and 390 nm at a tissue and detecting and quantifying the emission spectrum of the emitted beam at critical points chosen to optimize the difference between atherosclerotic plaque and structurally viable tissue. The presence of the atherosclerotic plaque is distinguished from structurally viable tissue by the presence or absence of the intensity of emissions at the critical points of optimum distinguishing wavelengths. 8

Title
Atherosclerotic identification
Application Number
7/298576
Publication Number
5046501
Application Date
January 18, 1989
Publication Date
September 10, 1991
Inventor
Richard Crilly
Ontario
CA
Agent
Kenneth I Kohn
Assignee
Wayne State University
MI, US
IPC
A61B 6/00
View Original Source